UNC-Chapel Hill, Dept of Ob/Gyn
Welcome,         Profile    Billing    Logout  
 6 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wu, Jennifer M
NCT03614221: Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis

Completed
2
22
RoW
Lindioil ointment, Indigo naturalis oil extract ointment, Protopic ointment 0.1%, Tacrolimus ointment 0.1%
Chang Gung Memorial Hospital, Ministry of Science and Technology, Taiwan
Atopic Dermatitis
12/21
12/21
SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

Active, not recruiting
2
134
US, RoW
SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo
Coherus Biosciences, Inc.
Hepatocellular Carcinoma
05/25
05/26
CARES, NCT04783012: Patient Removal of Catheters After Urogynecologic Surgery

Completed
N/A
120
US
Catheter removal
University of North Carolina, Chapel Hill
Urinary Retention Postoperative, Patient Satisfaction
07/22
09/22
NCT04985799: Comparing KIM to TVT Exact Sling

Completed
N/A
147
US
Gynecare TVT Exact Continence System, Midurethral sling, Neomedic KIM (Knotless Incontinence Mesh)
University of North Carolina, Chapel Hill
Stress Urinary Incontinence
05/23
06/24
FIT, NCT03811821: Fecal Incontinence Treatment () Study

Active, not recruiting
N/A
271
US
Biofeedback, Injection
Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of North Carolina, Chapel Hill, Colon and Rectal Surgery Associates, Ltd., Augusta University, RTI International, University of Alabama at Birmingham, University of Michigan
Fecal Incontinence, Bowel Incontinence
05/24
12/25
NCT06416982: Perineal Massage for Pessary Examinations

Recruiting
N/A
68
US
Perineal massage
University of North Carolina, Chapel Hill
Prolapse, Vaginal, Stress Urinary Incontinence, Pessaries, Pain
08/25
08/25
NCT03496051: Single Patient Access (Compassionate Use) for Continued Treatment of RO7070179 for Adult Subjects With Advanced Hepatocellular Carcinoma (HCC)

Available
N/A
US
RO7070179
New York University School of Medicine, Roche-Genentech
Hepatocellular Carcinoma
 
 

Download Options